Attila Szabo is a research fellow and faculty member at the Department of Immunology, Faculty of Medicine, University of Debrecen, Hungary. He holds two Master’s degrees in Molecular biology, Biochemistry (MSc) and in Philosophy (MA). He received his PhD degree in Biomedicine (2013) with a focus on cellular and molecular immunology. His research interest involves molecular signaling, biology of inflammation, psychoneuroimmunology, as well as biological psychiatry and psychopharmacology. He also strongly interested in the philosophical questions of mind-body interaction, psychosomatic phenomenon and the phenomenology of altered states of consciousness. Dr. Szabo has published more than 20 scientific papers and book chapters on these topics. His current research focuses on Serotonin and Sigma receptors, their biological activity and modulatory role on immune responses and cellular functions. In this context, he is specifically interested in the regulatory potential of Dymethyltryptamine (DMT) and its analogues (e.g. 5-MeO-DMT and Bufotenin) on human dendritic cell and lymphocyte functions under various conditions. As an invited speaker he has given many lectures at conferences and workshops emphasizing the emerging medical importance of DMT and Ayahuasca as potent therapeutic agents.